Search Results

Jean-Philippe Syed

Jean-Philippe Syed is a Partner at L1 Health, based in the Abu Dhabi office. He is responsible for the origination, execution, and management of global healthcare investment opportunities and for driving innovative value creation projects across the firm’s portfolio companies. JP also spearheads our regional engagement in the Middle East and India. JP brings over […]

LetterOne is pleased to announce a significant investment in Dayim Middle East Holding Company

LetterOne (L1) is pleased to announce a significant investment in Dayim Middle East Holding Company (“DMEH”), a leading equipment and truck logistics & leasing business in KSA and the broader Gulf Cooperation Council (“GCC”) region. The investment will fund DMEH’s continued growth. L1 is an independent, Luxembourg-based business with $20bn of long-term global investments across […]

L1 becomes minority shareholder in Harbour Energy plc after completion of transfer of Wintershall Dea assets

L1 becomes minority shareholder in Harbour Energy plc after completion of transfer of Wintershall Dea assets L1, together with BASF, has completed a transfer of the majority of Wintershall Dea’s upstream business to Harbour, the largest London-listed independent oil and gas company, for a total consideration of $11.2 billion. As a result of the transaction, […]

Alex Gourlay

Current: Executive Chair, Holland & Barrett Former: Co-COO, Walgreens Boots Alliance (until end 2021); Board member, Alliance Boots Group, Innovation Associates, Retail Industry Leaders Association, World Business Chicago, Business in the Community; Chairman, National Association of Chain Drug Stores

Franz Humer

Current: Chairman HMNC Holding Brain Health and the Humer Foundation; Board member of Allogene Therapeutics, Emil Frey Holdings; Advisor to Breakthrough Properties (US) Former: Chairman and CEO of Roche Holdings Inc; Chairman of Diageo, INSEAD Business School, International Centre for Missing and Exploited Children; Board member of Glaxo Holdings PLC, Citigroup Inc NY, Jacobs Holding […]

Stefan Linn

Stefan Linn is Managing Partner and CEO of L1 Health since 2020. Prior to joining LetterOne, Stefan was Chief Operating Officer of Oxford Immunotec, a NASDAQ listed diagnostics company focused on immune-related conditions, with responsibility for global commercial operations, manufacturing, supply chain, and product development. Before joining Oxford Immunotec, Stefan was a member of the […]

Michael Casey

Michael Casey is the Managing Partner of L1 Impact. Michael was previously a Senior Partner at L1 Retail and the Executive Chair/CEO of Holland & Barrett, Europe’s largest health and wellness retailer, where he oversaw a technology-led transformation. Prior to joining L1 Retail, Michael was a Managing Director at Goldman Sachs, where he was Head of Retail  in […]

Tim Summers

Tim Summers is the Managing Partner of L1 New Energy.  Prior to joining LetterOne, Tim has over 30 years of experience including multiple Chair, Board and Executive roles in manufacturing, engineering services and the energy sector in a variety of public and privately-owned businesses.  He has lived and worked in South America, the Middle East […]

Stephen Gillespie

Stephen Gillespie is General Counsel of LetterOne with responsibility for all legal, risk and compliance matters across the group. Born and educated in Northern Ireland, he read law at Trinity College, University of Oxford, and completed his legal education at The College of Law in Guildford.  He was admitted as a Solicitor of the Supreme […]

Josh Hardie

Josh joined LetterOne in 2021 as Corporate Affairs Director, overseeing the group’s external relationships with stakeholders, communications and working with L1 business on reputational and ESG issues. Josh was previously Deputy Director General at the CBI, leading all policy and influencing work through Brexit and the pandemic. Josh has also been a director at Tesco, […]